Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data.
Specenier, P M
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 2007 - 1856-60 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1569-8041
10.1093/annonc/mdm346 doi
Adult
Aged
Carcinoma, Squamous Cell--mortality
Combined Modality Therapy
Deoxycytidine--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Feasibility Studies
Female
Follow-Up Studies
Head and Neck Neoplasms--mortality
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Invasiveness--pathology
Neoplasm Staging
Radiotherapy Dosage
Radiotherapy, Adjuvant
Risk Assessment
Survival Analysis
Time Factors
Gemcitabine
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 2007 - 1856-60 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1569-8041
10.1093/annonc/mdm346 doi
Adult
Aged
Carcinoma, Squamous Cell--mortality
Combined Modality Therapy
Deoxycytidine--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Feasibility Studies
Female
Follow-Up Studies
Head and Neck Neoplasms--mortality
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Invasiveness--pathology
Neoplasm Staging
Radiotherapy Dosage
Radiotherapy, Adjuvant
Risk Assessment
Survival Analysis
Time Factors
Gemcitabine